Cooper EBITDA 2010-2024 | COO

Cooper EBITDA for the quarter ending October 31, 2024 was $0.289B, a 26.71% increase year-over-year.

  • Cooper 2024 EBITDA was 1.081B, a 19.98% increase from 2023.
  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Cooper EBITDA 2010-2024 | COO

  • Cooper 2024 EBITDA was 1.081B, a 19.98% increase from 2023.
  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$76.6B
Becton Dickinson (BDX)$71.6B
Cardinal Health (CAH)$30.9B
West Pharmaceutical Services (WST)$24.6B
Straumann Holding AG (SAUHY)$23.1B
Labcorp (LH)$20.6B
Align Technology (ALGN)$16.8B
Henry Schein (HSIC)$10B
Merit Medical Systems (MMSI)$6.3B
DENTSPLY SIRONA (XRAY)$3.9B
Patterson (PDCO)$2.7B
CONMED (CNMD)$2.2B
STAAR Surgical (STAA)$1.2B
Lifevantage (LFVN)$274M
Pro-Dex (PDEX)$141M